Tahata, Yuki
Sakamori, Ryotaro
Yamada, Ryoko
Kodama, Takahiro
Hikita, Hayato
Hagiwara, Hideki
Oshita, Masahide
Imai, Yasuharu
Hiramatsu, Naoki
Mita, Eiji
Kaneko, Akira
Miyazaki, Masanori
Ohkawa, Kazuyoshi
Hijioka, Taizo
Fukui, Hiroyuki
Ito, Toshifumi
Yamamoto, Keiji
Doi, Yoshinori
Yoshida, Yuichi
Yamada, Yukinori
Yakushijin, Takayuki
Tatsumi, Tomohide
Takehara, Tetsuo http://orcid.org/0000-0001-5036-3457
,
Funding for this research was provided by:
Gilead Sciences
Japan Agency for Medical Research and Development
Article History
Received: 13 January 2022
Accepted: 16 July 2022
First Online: 16 December 2022
Declarations
:
: Tetsuo Takehara received research grants from Gilead Sciences, Inc., Chugai Pharmaceutical Co., Ltd., MSD K. K., and Abbvie Inc., and was on the speakers’ bureau for Gilead Sciences, Inc., MSD K. K., and Abbvie Inc. All other authors have no conflicts of interest to disclose.